SEK0.125 0.0 13.6%
Last Trade - 09/04/21
Market Cap | £7.33m |
Enterprise Value | £6.09m |
Revenue | £52.8k |
Position in Universe | 1638th / 1831 |
Oct 23 (Reuters) - Chordate Medical Holding publ AB CMHM.NGM : * ONGOING CLINICAL STUDY ON CHRONIC MIGRAINE HAS RECEIVED THE GO-AHEAD FROM STUDY CLINICS IN FINLAND TO RESUME PATIENT RECRUITMENT, PAUSED DUE TO COVID-19 Source text for Eikon: ID:nBQN5QHSvQ Further company coverage: CMHM.NGM (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))